SMTL ID : 1hbj.1

X-ray Crystal structure of complex between Torpedo californica AChE and a reversible inhibitor, 4-Amino-5-fluoro-2-methyl-3-(3-trifluoroacetylbenzylthiomethyl)quinoline

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

homo-dimer

Ligands

2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 1 residues within 4Å: Chain A: N.416 No protein-ligand interaction detected (PLIP) NAG-NAG.6: 1 residues within 4Å: Chain B: N.416 No protein-ligand interaction detected (PLIP)

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 2 residues within 4Å: Chain A: N.59, S.61 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.59, A:S.61 NAG.7: 2 residues within 4Å: Chain B: N.59, S.61 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:N.59, B:S.61

2 x FBQ: 1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL(Covalent)

FBQ.3: 18 residues within 4Å: Chain A: G.80, W.84, G.117, G.118, G.119, Y.121, S.122, S.200, A.201, W.233, F.288, F.290, F.330, F.331, W.432, I.439, H.440 Ligands: PG4.5 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:W.84, A:W.84, A:W.84, A:F.330, A:F.330, A:F.331, A:F.331, A:W.432, A:I.439 Hydrogen bonds: A:G.118, A:G.119, A:A.201 pi-Stacking: A:W.84, A:W.84, A:W.84, A:H.440 FBQ.8: 18 residues within 4Å: Chain B: G.80, W.84, G.117, G.118, G.119, Y.121, S.122, S.200, A.201, W.233, F.288, F.290, F.330, F.331, W.432, I.439, H.440 Ligands: PG4.10 16 PLIP interactions: 16 interactions with chain B Hydrophobic interactions: B:W.84, B:W.84, B:W.84, B:F.330, B:F.330, B:F.331, B:F.331, B:W.432, B:I.439 Hydrogen bonds: B:G.118, B:G.119, B:A.201 pi-Stacking: B:W.84, B:W.84, B:W.84, B:H.440

2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)

MES.4: 9 residues within 4Å: Chain A: M.405, H.406, N.409, Q.500, R.515, V.518, C.521, N.525, Q.526 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:N.409, A:Q.500, A:N.525 Water bridges: A:Q.526 MES.9: 9 residues within 4Å: Chain B: M.405, H.406, N.409, Q.500, R.515, V.518, C.521, N.525, Q.526 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:N.409, B:Q.500, B:N.525 Water bridges: B:Q.526

2 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)

PG4.5: 5 residues within 4Å: Chain A: Y.121, W.279, F.330, Y.334 Ligands: FBQ.3 No protein-ligand interaction detected (PLIP) PG4.10: 5 residues within 4Å: Chain B: Y.121, W.279, F.330, Y.334 Ligands: FBQ.8 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:Y.121

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Doucet-Personeni, C. et al., A Structure-Based Design Approach to the Development of Novel, Reversible Ache Inhibitors. J.Med.Chem. (2001)

Release Date

2001-09-25

Peptides

ACETYLCHOLINESTERASE: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

ACETYLCHOLINESTERASE

Related Entries With Identical Sequence